New skin patch could heal burns better than standard care

NCT ID NCT06255990

Recruiting now Disease control Sponsor: University Children's Hospital, Zurich Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new material called NovoSorb BTM for treating deep skin wounds that need a skin graft. Researchers will compare it to the usual treatment in 42 people aged 1 to 75. They will check how elastic and healthy the healed skin looks after one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: NovoSorb BTM (a biodegradable dermal substitute)
What this could lead to: If successful, this could offer a better way to treat deep skin wounds, improving skin elasticity and appearance compared to current methods.
What could go wrong: This is an early observational study with only 42 participants, so results may not apply to everyone. The new substitute may not outperform standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SKIN TRANSPLANTATION

Contacts and locations

Locations

Cantonal Hospital Aarau
RECRUITING

Aarau, Canton of Aargau, 5001, Switzerland
Cantonal Hospital Winterthur
RECRUITING

Winterthur, Winterthur, 8400, Switzerland
University Children's Hospital Zurich
RECRUITING

Zurich, Canton of Zurich, 8032, Switzerland
University Hospital Zurich
RECRUITING

Zurich, Canton of Zurich, 8090, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.